Article
Safety, infectivity and immunogenicity of a genetically attenuated blood-stage malaria vaccine
21 Nov 2021
Abstract excerpt
Abstract Background There is a clear need for novel approaches to malaria vaccine development. We aimed to develop a genetically attenuated blood-stage vaccine and test its safety, infectivity, and immunogenicity in healthy volunteers. Our approach was to target the gene encoding the knob-associated histidine-rich protein (KAHRP), which is responsible for the assembly of knob structures at the infected...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
